Pharmacovigilance and Safety Assessment

Pharmacovigilance and safety assessment are critical components of drug development and post-market surveillance, ensuring the safety and efficacy of pharmaceutical products. Pharmacovigilance involves the monitoring, detection, assessment, and prevention of adverse drug reactions (ADRs) or other drug-related problems. Safety assessments include preclinical and clinical trials, where potential risks are evaluated in controlled environments, followed by real-world monitoring once the drug is marketed. This ongoing process helps identify rare or long-term side effects and ensures that the benefits of a drug continue to outweigh the risks. Effective pharmacovigilance promotes public health and regulatory compliance, supporting patient safety across diverse therapeutic areas.

 

    Related Conference of Pharmacovigilance and Safety Assessment

    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    February 25-26, 2026

    15th International Conference on Herbal Medicine and Acupuncture

    Aix-en-Provence, France
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Pharmacovigilance and Safety Assessment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in